Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PubMed laboratory research record [PMID: 33626846] PubMed record related to this compound for laboratory literature review
Nascobal may be prescribed for individuals with: Pernicious anemia Post-gastric bypass or GI surgery Chronic atrophic gastritis B12 deficiency due to Crohns disease or other GI conditions Long-term use of metformin or acid-reducing medications Vegetarian or vegan diet with inadequate B12 intake It is not intended for use in those with nasal congestion or damage to nasal tissue unless otherwise advised by a healthcare provider
The concentration of the peptide reaching the bloodstream is determined by the dosage and the quality of the product, not by what's in your stomach
The accepted codes are E53.8 (B group vitamin deficiency), D51.0 (pernicious anemia), and D51.9 (B12 deficiency anemia, unspecified)
US$ 26.57
US$ 25.47
US$ 22.52
US$ 27.31
